Recine Nadia, et al.
Archives of gynecology and obstetrics, 2016
Abstract
Purpose
Bacterial vaginosis (BV) is the most prevalent lower genital tract infection in reproductive-age women worldwide. BV is an ecological disorder of the vaginal microbiota characterized microbiologically by replacement of the lactobacilli, predominant vaginal microbiota. It is characterized by a high rate of relapse in sexual active women, and these patients show three or more relapses each year. A healthy vagina is characterized by hydrogen peroxide and acid-producing lactobacilli, which are crucial to maintain the physiological vaginal ecosystem and their depletion speeds up bacterial overgrowth with pH elevation, salidase and amine production, leading to the observed signs and symptoms of BV. The aim of this study is to evaluate the efficacy of long-term vaginal lactobacilli's implementation in restoring and maintaining vaginal microflora and pH and to collect data about prophylactic approach based on probiotics supplementation with lactobacilli.
Methods
This is a prospective case-control study, performed between January 2013 and September 2014 at Department of Gynecological Obstetrics and Urologic Sciences of "Sapienza" University of Rome. 250 non-pregnant sexually active women with diagnoses of BV were collected. Patients selected were divided in Group A (125 patients assigned to standard treatment for BV-metronidazole 500 mg orally twice a day for 7 days) and Group B (125 women undergoing the same standard antibiotic regimen followed by vaginal tablets containing Lactobacillus rhamnosus BMX 54). Patients were evaluated after 2, 6, and 9 months (T0, T2, T6, and T9) in term of recurrences rates of BV, vaginal symptoms, re-establishment of healthy vaginal flora, vaginal pH, and treatment tolerability.
Results
Vaginal flora was significantly replaced in Group B patients after 2 months comparing with Group A (p = 0.014). These data were confirmed at 6 and 9 months follow-up: patients that underwent prophylactic therapy with NORMOGIN(®) experienced significantly low rate of recurrences comparing with patients treated with antibiotics only (p < 0.001). During follow-up patients continuing supplementation had significant pH decrease respect to other patients (p < 0.001 at 9 months follow-up visit).
Conclusions
Probiotic supplementation with vaginal Lactobacillus rhamnosus BMX54 seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of BV, in particular in high-risk patients.
Keywords
Bacterial vaginosis; Lactobacillus rhamnosus BMX54; Probiotics; Vaginal flora.
PMID: | 26142892 |
---|---|
DOI: | 10.1007/s00404-015-3810-2 |
Category: | Women's Health |
The best supplements with Lactobacillus Rhamnosus in Women's Health category:
- Woman's Probiotic 20 Billion, 50 Veggie Caps (Now Foods) - Now Women's Probiotic has been specially formulated using three clinically tested probiotic strains to support women's health through every stage of life. It contains among others: Lactobacillus Rhamnosus.
Articles similar to "Restoring Vaginal Microbiota: Biological Control of Bacterial Vaginosis. A Prospective Case-Control Study Using Lactobacillus Rhamnosus BMX 54 as Adjuvant Treatment Against Bacterial Vaginosis."
- The significance of Lactobacillus Rhamnosus for Women's Health: Effects of Probiotics on the Recurrence of Bacterial Vaginosis: A Review. (Objective: Bacterial vaginosis (BV) is a common cause of genital discomfort in women in reproductive ages, which causes many complications... Although the results of different studies are controversial, most studies have been in favor of the probiotics in the prevention or treatment of BV, and no adverse effects have been reported. Therefore, it may be helpful to recommend daily consumption of probiotic products to improve public health among women.)
- The role of Lactobacillus Rhamnosus in Women's Health: Long-term Lactobacillus Rhamnosus BMX 54 Application to Restore a Balanced Vaginal Ecosystem: A Promising Solution Against HPV-infection. ( Over recent years, a growing interest has developed in microbiota and in the concept of maintaining a special balance between Lactobacillus and other bacteria species in order to promote women's well-being... The consistent percentage of clearance of PAP-smear abnormalities and HPV-clearance obtained in long-term treatment group has been interestingly high and encouraging. Obviously, larger and randomized studies are warranted to confirm these encouraging results, but we believe that eubiosis re-establishment is the key to tackle effectively even HPV-infection. )
- The impact of Lactobacillus Rhamnosus on Women's Health: Probiotics in the Prevention of Recurrences of Bacterial Vaginosis. (Context: Bacterial vaginosis (BV) is the most common cause of vaginal discharge in women during their fertile years...)
- The significance of Lactobacillus Rhamnosus for Women's Health: Effect of a Yoghurt Drink Containing Lactobacillus Strains on Bacterial Vaginosis in Women - A Double-Blind, Randomised, Controlled Clinical Pilot Trial. (Bacterial vaginosis (BV) is characterised by a depletion of lactobacilli in favour of an overgrowth of anaerobic bacteria...)
- The role of Lactobacillus Rhamnosus in Women's Health: Effects of Lactobacillus Rhamnosus and Lactobacillus Acidophilus on Bacterial Vaginal Pathogens. (The human vagina is colonized by a variety of microbes...)
- The significance of Lactobacillus Rhamnosus for Women's Health: Evidence-based Mixture Containing Lactobacillus Strains and Lactoferrin to Prevent Recurrent Bacterial Vaginosis: A Double Blind, Placebo Controlled, Randomised Clinical Trial. (Bacterial vaginosis (BV) is the most common cause of vaginal discomfort in women...)
- The role of Lactobacillus Rhamnosus in Women's Health: Effectiveness of Vaginal Administration of Lactobacillus Rhamnosus Following Conventional Metronidazole Therapy: How to Lower the Rate of Bacterial Vaginosis Recurrences. (Eighty-four patients with bacterial vaginosis diagnosed according to Amsel's criteria were randomized to receive either oral metronidazole 500 mg twice a day for seven days, or one vaginal tablet containing freeze-dried Lactobacillus rhamnosus once a week at bedtime for two months starting one week after the last antibiotic administration...)
Previous article
Effects of Probiotics on the Recurrence of Bacterial Vaginosis: A Review.
Next article
Effects of Lactobacillus Rhamnosus and Lactobacillus Acidophilus on Bacterial Vaginal Pathogens.